Molecular biology of human papillomavirus infection and cervical cancer
The DOI matches its Crossref record; 172 of the 179 references it cites were found in a registry or an index.
Abstract
HPVs (human papillomaviruses) infect epithelial cells and cause a variety of lesions ranging from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types have been identified so far, with a subset of these being classified as high risk. High-risk HPV DNA is found in almost all cervical cancers (>99.7%), with HPV16 being the most prevalent type in both low-grade disease and cervical neoplasia. Productive infection by high-risk HPV types is manifest as cervical flat warts or condyloma that shed infectious virions from their surface. Viral genomes are maintained as episomes in the basal layer, with viral gene expression being tightly controlled as the infected cells move towards the epithelial surface. The pattern of viral gene expression in low-grade cervical lesions resembles that seen in productive warts caused by other HPV types. High-grade neoplasia represents an abortive infection in which viral gene expression becomes deregulated, and the normal life cycle of the virus cannot be completed. Most cervical cancers arise within the cervical transformation zone at the squamous/columnar junction, and it has been suggested that this is a site where productive infection may be inefficiently supported. The high-risk E6 and E7 proteins drive cell proliferation through their association with PDZ domain proteins and Rb (retinoblastoma), and contribute to neoplastic progression, whereas E6-mediated p53 degradation prevents the normal repair of chance mutations in the cellular genome. Cancers usually arise in individuals who fail to resolve their infection and who retain oncogene expression for years or decades. In most individuals, immune regression eventually leads to clearance of the virus, or to its maintenance in a latent or asymptomatic state in the basal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“human papillomavirus (HPV) is thought to initiate cervical carcinoma and squamous cell carcinoma of the head and neck in part by inactivating RB through expression of the E7 oncoprotein21,22”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
In the citing paper
“in HPV-induced cervical cancers, the virus initiates cancer in dividing cells in the basal layer of the epithelium, preventing their normal cell cycle exit and maturation21.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Barrier Function of the Skin: “La Raison d'Être” of the Epidermis
Madison, K. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12359.x · Cited by 1,188
Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Münger, K., Phelps, W. C., Bubb, V, Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,030
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 974
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Research works printed but not linked: 2
- Villiers de, 2001, Taxonomic classification of papillomaviruses, Papillomavirus Rep., 12, 57
- Sorathia, 2004, The E4 protein of HPV16 Interacts with E2 and regulates the trans-activation and replication functions of E2, 318
Cited by
Items 301–400 of 1,000
González‐Moles, M. Á., Pino, C. K.-D., & Ramos‐García, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113099 · Cited by 34
“Alterations in the RB tumor suppressor gene are important in tumor initiation and early progression of neoplasms, as has been demonstrated in members of families that inherit alterations in RB alleles that predispose them to the development of familial retinoblastoma [97–99], as well as in carcinomas of the uterine ce…”
BackgroundHuman papillomavirus early proteins and apoptosis
Cai, Q., Lv, L., Shao, Q., Li, X., & Dian, A. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2665-z · Cited by 38
Ma, W., Tummers, B., van Esch, E. M. G., Goedemans, R., Melief, C. J. M., Meyers, C., Boer, J. M., & van der Burg, S. H. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00496 · Cited by 35
“Cell Host Microbe (2015) 17(2):229–42.”
InfluentialUpsetting the Balance: When Viruses Manipulate Cell Polarity Control
Thomas, M., & Banks, L. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.04.016 · Cited by 32
“HPV replication occurs in terminally differentiating keratinocytes and is completely dependent upon the differentiation program of the epithelium [40].”
BackgroundRieck, G. C., & Fiander, A. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700138 · Cited by 31
Broccolo, F., Fusetti, L., Rosini, S., Caraceni, D., Zappacosta, R., Ciccocioppo, L., Matteoli, B., Halfon, P., Malnati, M., & Ceccherini‐Nelli, L. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23487 · Cited by 31
“This may be explained by viral integration into the host genome and the observed loss of viral replication upon integration [Doorbar, 2006].”
BackgroundEtiological role of human papillomavirus infection for inverted papilloma of the bladder
Shigehara, K., Sasagawa, T., Doorbar, J., Kawaguchi, S., Kobori, Y., Nakashima, T., Shimamura, M., Maeda, Y., Miyagi, T., Kitagawa, Y., et al. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21966 · Cited by 30
“We also investigated the expression of HPV-E4 and L1 proteins that are concordant with cell cycle arrest and HPV propagation [Doorbar, 2006].”
BackgroundMethodSelf-citationZanotta, N., Tornesello, M. L., Annunziata, C., Stellato, G., Buonaguro, F. M., & Comar, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151851 · Cited by 31
“During normal HPV replication, which takes place within maturing squamous epithelium, HPV remains hidden from the host immune system, suggesting that the opportunity for HPV to induce or modulate specific immune responses is limited [10].”
BackgroundKim, S. C., Feldman, S., & Moscicki, A. (2017) · Rheumatology · doi:10.1093/rheumatology/kex523 · Cited by 33
van den Heuvel, C. N. A. M., Loopik, D. L., Ebisch, R. M. F., Elmelik, D., Andralojc, K. M., Huynen, M. A., Bulten, J., Bekkers, R. L. M., Massuger, L. F. A. G., Melchers, W. J. G., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0369-7 · Cited by 45
Gregorio, V. D., Urciuolo, F., Netti, P. A., & Imparato, G. (2020) · Cancers · doi:10.3390/cancers12051150 · Cited by 30
Cunha, A. P. A., Belfort, I. K. P., Mendes, F. P. B., dos Santos, G. R. B., Costa, L. H. D. L., Monteiro, P. D. M., Gaspar, R. L., Ferreira, M. B., Ferreira, A. D. S., Monteiro, S. C. M., et al. (2020) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2020/8838317 · Cited by 33
“Other factors such as persistence and oncogenic viral type, the expression of viral oncogenes, and the integration of the viral genome in the host cell also have an important influence on cervical carcinogenesis [27].”
BackgroundBuza, N. (2021) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2021.10.006 · Cited by 35
The Critical Role of Ferroptosis in Hepatocellular Carcinoma
Pan, F., Lin, X., Hao, L., Wang, T., Song, H., & Wang, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.882571 · Cited by 32
“Loss of Rb is involved in initiation of cancers including retinoblastoma, HPV, small-cell lung carcinoma, and HCC (Meuwissen et al., 2003; Doorbar, 2006; Mayhew et al., 2007; Munakata et al., 2007; Dimaras et al., 2008).”
BackgroundRedox control of viral carcinogenesis: The human papillomavirus paradigm
Foppoli, C., Marco, F. D., Cini, C., & Perluigi, M. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.12.016 · Cited by 37
“These perturbations create the conditions permissive for viral replication which, at the same time, happen to be conducive to cancer development; iv) the viral replicative cycle is in turn strictly controlled by the host, with the viral progeny maturation strictly synchronized on cell differentiation program [11]; v)…”
Schneider, M. A., Scheffer, K. D., Bund, T., Boukhallouk, F., Lambert, C., Cotarelo, C., Pflugfelder, G. O., Florin, L., & Spoden, G. A. (2013) · Journal of Virology · doi:10.1128/jvi.01803-12 · Cited by 32
“The composition of the factors binding and regulating the LCR is dependent on differentiation of the host keratinocytes (22, 23).”
BackgroundLechanteur, A., Furst, T., Évrard, B., Delvenne, P., Hubert, P., & Piel, G. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.02.041 · Cited by 32
“About 200 different types of HPV have been identified and a few of them present high risk (HPV16, 18, 31, 33, 35) and are responsible for cancers (Doorbar, 2006; Doorbar et al., 2012; Haedicke and Iftner, 2013; Herfs et al., 2012).”
BackgroundHPV-Induced Field Cancerisation: Transformation of Adult Tissue Stem Cell Into Cancer Stem Cell
Olivero, C., Lanfredini, S., Borgogna, C., Gariglio, M., & Patel, G. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00546 · Cited by 31
“…deregulate cell growth by disruption of pRb (retinoblastoma protein) binding to the E2F family of transcription factors though E7 binding pRb. Host p21 and p27 cyclin-dependent kinase inhibitors moderate the ability of E7 to drive cell proliferation in some cells (Doorbar, 2006; Tomaić, 2016).”
BackgroundPrecancerous Lesions of the Cervix
Wright, T. C., Ronnett, B. M., Kurman, R. J., & Ferenczy, A. S. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0489-8_5 · Cited by 30
Gene Discovery in Cervical Cancer: Towards Diagnostic and Therapeutic Biomarkers
Martin, C. M., Kehoe, L., Spillane, C. D., & O’Leary, J. J. (2007) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256249 · Cited by 31
Tavares, M. C. M., Júnior, S. F. D. L., Coelho, A. V. C., Marques, T. R. N. M., de Araújo, D. H. T., Heráclio, S. D. A., Amorim, M. M. R., de Souza, P. R. E., & Crovella, S. (2015) · Annals of Human Biology · doi:10.3109/03014460.2014.1001436 · Cited by 30
“The persistence of HPV infection, especially the high-risk oncogenic types, can cause epithelial alterations, called Cervical Intraepithelial Neoplasm (CIN) or Squamous Intraepithelial Lesions (SIL) (Doorbar, 2006; Lizano et al., 2009; Lowy & Howley, 2001; Mammas et al., 2014; Tommasino, 2014).”
BackgroundKrüppel, U., Müller‐Schiffmann, A., Baldus, S. E., Smola, S., & Steger, G. (2008) · Virology · doi:10.1016/j.virol.2008.04.006 · Cited by 30
“In the suprabasal layers of the infected epithelium, E6 and E7 are expressed from P 97 to induce cell proliferation and allow genome maintenance (reviewed in Doorbar, 2006).”
Protease-activated receptor-2 (PAR-2) in cervical cancer proliferation
Sánchez‐Hernández, P. E., Ramírez‐Dueñas, M. G., Albarran-Somoza, B., García‐Iglesias, T., Toro‐Arreola, A. D., Franco‐Topete, R. A., & Daneri‐Navarro, A. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.083 · Cited by 30
“In fact, HPV E6 and E7 proteins regulate cell proliferation in cervical epithelium [33].”
BackgroundInter-laboratory validation of PCR-based HPV detection in pathology specimens
Petersen, I., Schewe, C., Schlüns, K., Dietel, M., Speich, N., Schmitt, C. A., Bollmann, M., Sotlar, K., Bültmann, B. D., Dours-Zimmermann, M. T., et al. (2007) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-007-0437-0 · Cited by 29
“The biology of HPV infection and its potential progression to cancer is complex [ 13 ].”
BackgroundLima, K. M. G., Gajjar, K. B., Valasoulis, G., Nasioutziki, M., Kyrgiou, M., Karakitsos, P., Paraskevaidis, E. A., Martin‐Hirsch, P. L., & Martin, F. L. (2014) · Analytical Methods · doi:10.1039/c4ay01736f · Cited by 29
Wilting, S. M., Miok, V., Jaspers, A., Boon, D., Sørgård, H., Lando, M., Snoek, B. C., van Wieringen, W. N., Meijer, C. J. L. M., Lyng, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9698 · Cited by 30
“The latter is considered a driver of further cellular transformation [1].”
Liu, Y., Wang, Y., Chen, C., Zhang, J., Qian, W., Dong, Y., Liu, Z., Zhang, X., Wang, X., Zhang, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13516 · Cited by 29
“Human papilloma virus (HPV), a small, circular, double-stranded DNA virus infecting epithelial cells, has been reported to be necessary but not sufficient to induce tumorigenesis in host squamous epithelial cells [3, 4].”
BackgroundWasserman, P., Rubin, D. S., & Turett, G. S. (2017) · AIDS Patient Care and STDs · doi:10.1089/apc.2017.0063 · Cited by 31
“The activities of these proteins lead to behavioral changes and DNA modifications at the sequence, epigenetic, and cytogenetic levels.(52) Indeed, the most plausible argument for identifying and treating anal neoplasia resides in the literature documenting these cellular changes and DNA modifications.”
InfluentialPrevalence of human papillomavirus detection in ovarian cancer: a meta-analysis
Cherif, S., Amine, A., Thies, S., TAUBE, E. T., Braicu, E. I., Sehouli, J., & Kaufmann, A. M. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04282-7 · Cited by 29
“The overexpression of E6 and E7 oncoproteins are required to maintain malignant transformation in HPV-related cancers, which should be detected by specific primers for E6/E7 regions [54, 55].”
BackgroundGupta, A., & Kumar, M. (2015) · Scientific Reports · doi:10.1038/srep12522 · Cited by 29
“All exhaustive clinical studies reporting (1) the integration and breakpoint events in HPV associated carcinomas (2) HPVs methylation events relevant to the cancer clinical outcomes and (3) the HPV mediated aberrant expression of distinct host miRNAs that are crucial in cancer etiology were included and analyzed.”
BackgroundWaldstrøm, M., & Ørnskov, D. (2011) · Cytopathology · doi:10.1111/j.1365-2303.2011.00923.x · Cited by 29
“Infection with oncogenic types of HPV is extremely common, especially among younger women, and most infections are transient and typically resolve within 6–24 months.7,8 This is reflected in the relatively low specificity of the HPV DNA tests, leading to false-positive results and consequently control and referral of…”
BackgroundJiménez-Pérez, M. I., Jave‐Suárez, L. F., Ortiz‐Lazareno, P. C., Bravo‐Cuéllar, A., González‐Ramella, O., Aguilar‐Lemarroy, A., Hernández‐Flores, G., Pereira-Suárez, A. L., Daneri‐Navarro, A., & del Toro‐Arreola, S. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-7 · Cited by 29
“Human papillomavirus (HPV) infection is the most important risk factor for cervical cancer development [2,3]; persistence of high-risk HPV infection leads to premalignant lesions and may ultimately lead to cervical cancer in a multistep process [4,5].”
BackgroundPathogenMip Assay: A Multiplex Pathogen Detection Assay
Akhras, M. S., Thiyagarajan, S., Villablanca, A., Davis, R. W., Nyrén, P., & Pourmand, N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000223 · Cited by 29
“We developed a 24-plex PathogenMip assay to target HPV genotypes commonly associated with cervical cancer progressions [21].”
MethodHuman papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation
Qian, G., Wang, D., Magliocca, K. R., Hu, Z., Nannapaneni, S., Kim, S., Chen, Z., Sun, S., Shin, D. M., Saba, N. F., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.06.006 · Cited by 28
“HPV oncoproteins, E6 and E7, contribute most to the transforming activity of high risk HPVs, maintenance of the transformed phenotype, and proliferative capability (6, 7).”
Cerasuolo, A., Annunziata, C., Tortora, M., Starita, N., Stellato, G., Greggi, S., Maglione, M. G., Ionna, F., Losito, S., Botti, G., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15977 · Cited by 28
“During the productive phase of HPV infection the viral genomes markedly replicate in the spinous layers and are encapsidated in the upper terminally differentiated epithelia where the late viral genes L1 and L2 are highly expressed [15, 20].”
Wechsler, E. I., Tugizov, S. M., Herrera, R., Costa, M. D., & Palefsky, J. M. (2018) · Journal of General Virology · doi:10.1099/jgv.0.001061 · Cited by 28
“AKC2 raft cultures also phenotypically resembled HSIL/invasive cancer based on their H&E appearance and expression patterns of established HPV-associated biomarkers including MCM (E7 surrogate marker) and p16, which are both associated with E7 overexpression [35, 40].”
BackgroundOncoviruses: Induction of cancer development and metastasis by increasing anoikis resistance
Amjad, Z. S., Shojaeian, A., Nahand, J. S., Bayat, M., Taghizadieh, M., Rostamian, M., Babaei, F., & Moghoofei, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22598 · Cited by 30
“It ’ s conceivable that vGPCR promotes EC survival by activating the NF-k β signaling pathway through the PI3K/Akt pathway [175].”
BackgroundRafael, T. S., Rotman, J., Brouwer, O. R., van der Poel, H. G., Mom, C. H., Kenter, G. G., de Gruijl, T. D., & Jordanova, E. S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11041101 · Cited by 29
“Infection with low-risk HPV types mainly causes skin lesions such as anogenital warts, whereas persistent infection with hrHPV types increases the risk of dysplasia and cancerous lesions [4].”
BackgroundCidofovir selectivity is based on the different response of normal and cancer cells to DNA damage
Schutter, T. D., Andreï, G., Topalis, D., Naesens, L. M. J., & Snoeck, R. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-18 · Cited by 29
“DNA synthesis machinery for its genome replication [2].”
Trushin, N., Alam, S., El‐Bayoumy, K., Krzeminski, J., Amin, S., Gullett, J., Meyers, C., & Prokopczyk, B. (2012) · Journal of Carcinogenesis · doi:10.4103/1477-3163.92309 · Cited by 27
“end of the viral replication cycle and is a critical step in the development of cervical cancer.[5]”
BackgroundCastle, P. E., Follansbee, S., Borgonovo, S., Tokugawa, D., Schwartz, L. M., Lorey, T. S., LaMere, B. J., Gage, J. C., Fetterman, B. J., Darragh, T. M., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0984 · Cited by 27
“tions, as E6/E7 must be expressed for genome maintenance in productive HPV infections (36).”
Somatic structural variation and cancer
Tubío, J. M. C. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv016 · Cited by 29
Immunohistochemistry in Gynecologic Pathology: An Example-Based Practical Update
Buza, N., & Hui, P. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0541-ra · Cited by 27
“Rb, leading to upregulation of p16 (cyclin-dependent kinase inhibitor) by disruption of the negative feedback loop.(11) Thus, immunohistochemical detection of p16 protein overexpression (p16 positivity)—defined as continuous strong nuclear or nuclear and cytoplasmic staining in a ‘‘blocklike’’ pattern involving at lea…”
BackgroundHuman papilloma virus: An etiological and prognostic factor for oral cancer?
Lafaurie, G. I., Perdomo, S. J., Buenahora, M. R., Amaya, S., & Díaz‐Báez, D. (2018) · Journal of Investigative and Clinical Dentistry · doi:10.1111/jicd.12313 · Cited by 27
HPV73 a nonvaccine type causes cervical cancer
Filho, S. M. A., Gradíssimo, A., Usyk, M., Moreira, F. C. B., de Almeida, L. M., Moreira, M. Â. M., & Burk, R. D. (2019) · International Journal of Cancer · doi:10.1002/ijc.32315 · Cited by 28
“spliced transcripts, integration of HPV DNA into the cancer cell genome, and expression of E6 and E7 oncoproteins.(2,3) HPV73 is currently classified as possibly carcinogenic based”
BackgroundPani, S., Mohapatra, S., Sahoo, A., Baral, B., & Debata, P. R. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22947 · Cited by 27
Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2
Gammoh, N., Isaacson, E. R., Tomaić, V., Jackson, D. J., Doorbar, J., & Banks, L. (2009) · Oncogene · doi:10.1038/onc.2009.78 · Cited by 27
“Human papillomaviruses (HPVs) are the main oncogenic factors associated with the development of cervical cancer (Doorbar, 2006).”
BackgroundSelf-citationBarzon, L., Giorgi, C., Buonaguro, L., Palù, G., & the Italian Society for Virology (2008) · Infectious Agents and Cancer · doi:10.1186/1750-9378-3-14 · Cited by 31
“Several basic experimental studies have clarified the mechanisms of HPV oncogenesis [29,32].”
BackgroundPocket Proteins Suppress Head and Neck Cancer
Shin, M.-K., Pitot, H. C., & Lambert, P. F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2833 · Cited by 26
“HR-HPV E6 binds to and induces to the degradation of p53, while HR-HPV E7 binds to and induces degradation of pRb and its related pocket protein family members, p107 and p130 (11-12).”
BackgroundHPV shapes tumor transcriptome by globally modifying the pool of RNA binding protein-binding motif
Wu, Y. C., Chen, H., Chen, Y., Qu, L., Zhang, E., Wang, Z., Wu, Y., Yang, R., Mao, R., Lu, C., et al. (2019) · Aging · doi:10.18632/aging.101927 · Cited by 27
“HPV is a small DNA virus and infects mucosal epithelia [7].”
BackgroundWang, Z., Liu, C., Liu, W., Lv, X., Hu, T., Yang, F., Yang, W., He, L., & Huang, X. (2024) · BMC Genomics · doi:10.1186/s12864-024-10101-y · Cited by 27
Barnoud, T., Donninger, H., & Clark, G. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.697557 · Cited by 27
“Subsequent studies have identified alterations in the Rb gene or inactivation of the Rb protein in a variety of human cancers (24, 25), and it is now widely accepted that the inactivation of the Rb protein may be one of the most frequent events in cancer (26).”
BackgroundSerum Immune Profiling for Early Detection of Cervical Disease
Ewaisha, R., Panicker, G., Maranian, P., Unger, E. R., & Anderson, K. S. (2017) · Theranostics · doi:10.7150/thno.21098 · Cited by 29
“The expression of E4 in CIN II and III is restricted to this subset of cells and is generally lost in ICC [54].”
BackgroundMaver, P. J., Kocjan, B. J., Seme, K., Potočnik, M., Gale, N., & Poljak, M. (2011) · Journal of Medical Virology · doi:10.1002/jmv.21994 · Cited by 25
“It is thought that they have the ability to modulate cell signaling, possess transforming activity, play a role in the stimulation of cell proliferation and, together, with theHPVE6proteins induce koilocytosis [Doorbar, 2006; Krawczyk et al., 2008].”
BackgroundAhmad, A., Tiwari, R. K., Mishra, P., Alkhathami, A. G., Almeleebia, T. M., Alshahrani, M. Y., Ahmad, I. S., Asiri, R. A., Alabdullah, N. M., Hussien, M., et al. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.01.054 · Cited by 25
González‐Moles, M. Á., Warnakulasuriya, S., López-Ansio, M., & Ramos‐García, P. (2022) · Cancers · doi:10.3390/cancers14153834 · Cited by 28
“It has also been shown in cervical and oropharyngeal cancer, closely associated with HPV infection, that these viruses inactivate pRb through their E7 oncoprotein, this being the mechanism of oncogenic initiation [150,151], and similar findings have been documented for virus-induced hepatocarcinoma [152].”
BackgroundJackson, R., Togtema, M., Lambert, P. F., & Zehbe, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101540 · Cited by 29
“Like other transforming DNA viruses, HPV16 encodes viral oncoproteins, which act synergistically in infected keratinocytes [5].”
BackgroundBarillari, G., Monini, P., Sgadari, C., & Ensoli, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051418 · Cited by 26
“Generally, an effective immune response to HPV develops within months after infection, resulting in viral clearance [3,10].”
BackgroundXiong, Y., Cui, L., Bian, C., Zhao, X., & Wang, X. (2020) · Medicine · doi:10.1097/md.0000000000023155 · Cited by 28
DNAJB1 stabilizes MDM2 and contributes to cancer cell proliferation in a p53-dependent manner
Qi, M., Zhang, J., Zeng, W., & Chen, X. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.12.003 · Cited by 26
Abe, S., Miura, K., Kinoshita, A., Mishima, H., Miura, S., Yamasaki, K., Hasegawa, Y., 東島, 愛., Jo, O., Sasaki, K., et al. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.7 · Cited by 24
Human papillomavirus genotypes in Iranian patients with cervical cancer
Shahsiah, R., Khademalhosseini, M., Mehrdad, N., Ramezani, F., & Nadji, S. A. (2011) · Pathology - Research and Practice · doi:10.1016/j.prp.2011.09.011 · Cited by 24
Association of the miR-17-5p variants with susceptibility to cervical cancer in a Chinese population
Jin, T., Wu, X., Yang, H., Liu, M., He, Y., He, X., Shi, X., Wang, F., Du, S., Ma, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12299 · Cited by 24
Regulation of HPV E7 Stability by E6-Associated Protein (E6AP)
Vats, A., Trejo-Cerro, Ó., Massimi, P., & Banks, L. (2022) · Journal of Virology · doi:10.1128/jvi.00663-22 · Cited by 24
Alternative splicing in human tumour viruses: a therapeutic target?
Hernandez-Lopez, H. R., & Graham, S. V. (2012) · Biochemical Journal · doi:10.1042/bj20120413 · Cited by 24
“and Doorbar, J. (2009) A novel interaction between the human papillomavirus”
BackgroundFollow-up Study of Patients With Cervical Intraepithelial Neoplasia Grade 1 Overexpressing p16Ink4a
Cortecchia, S., Galanti, G., Sgadari, C., Costa, S., Lillo, M. D., Caprara, L., Barillari, G., Monini, P., Nannini, R., Ensoli, B., et al. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182a80b14 · Cited by 24
“T p16 Ink4a (p16) tumor-suppressor protein is a direct marker of the oncogenic activity of all high-risk human papillomavirus (HPV) types.(1) In normal cells, p16 inhibits the activity of cyclin-dependent kinases CDK4/6, and its expression is negatively controlled by the Rb gene product.”
Peralta-Zaragoza, Ó., Deas, J., Gómez-Cerón, C., García-Suástegui, W. A., Fierros-Zárate, G. D. S., & Jacobo-Herrera, N. J. (2013) · Obstetrics and Gynecology International · doi:10.1155/2013/912780 · Cited by 27
“…2013 Academic Editor: W. T. Creasman Copyright © 2013 Oscar Peralta-Zaragoza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.”
Sauter, J. L., Mount, S. L., John, T. L. S., Wojewoda, C. M., Bryant, R. J., & Leiman, G. (2014) · Acta Cytologica · doi:10.1159/000358246 · Cited by 24
Helfer, C. M., Wang, R., & You, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077994 · Cited by 24
“The pcDNA4C-NLS-LacI plasmid was generated by cloning a nuclear localization sequence (NLS) into the pcDNA4C vector using a BamHI site and the PCR-amplified LacI cDNA fragment into the pcDNA4C vector using BamHI and EcoRI sites.”
BackgroundInfluentialGarcía-Bates, T. M., Kim, E. Y., Concha‐Benavente, F., Trivedi, S., Mailliard, R. B., Gambotto, A. A., & Ferris, R. L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502027 · Cited by 24
“The HPV oncoproteins E6 and E7 are known to initiate malignant transformation by inactivating the tumor suppressors p53 and Rb, respectively (5, 14).”
Human Papillomavirus-Specific Immune Therapy: Failure and Hope
Nieto, K., Gissmann, L., & Schädlich, L. (2010) · Antiviral Therapy · doi:10.3851/imp1665 · Cited by 25
“Progression from a productive HPV infection towards a high-grade lesion and cancer is characterized by the change in the typically well-controlled pattern of viral gene expression [10].”
BackgroundPhusingha, P., Ekalaksananan, T., Vatanasapt, P., Loyha, K., Promthet, S. S., Kongyingyoes, B., Patarapadungkit, N., Chuerduangphui, J., & Pientong, C. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24744 · Cited by 24
“Nowadays, it is well known that HPV infection is the cause of over 99% of cervical cancers.(18) Although many HPV infections spontaneously resolve within 2 years, individuals with persistent infection of HR-HPV are at risk of developing cervical cancer.”
BackgroundLakshmi, S., Rema, P., & Somanathan, T. (2009) · Pathobiology · doi:10.1159/000209392 · Cited by 24
Human papillomavirus in cervical screening and vaccination
Crosbie, E. J., & Kitchener, H. C. (2006) · Clinical Science · doi:10.1042/cs20050230 · Cited by 28
Pani, S., Sahoo, A., Patra, A., & Debata, P. R. (2020) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2061 · Cited by 23
Potential role of human papillomavirus proteins associated with the development of cancer
Balaji, D., Kalarani, I. B., Mohammed, V., & Veerabathiran, R. (2022) · VirusDisease · doi:10.1007/s13337-022-00786-8 · Cited by 23
Keratinocytes sense and eliminate CRISPR DNA through STING/IFN-κ activation and APOBEC3G induction
Sarkar, M. K., Uppala, R., Zeng, C., Billi, A. C., Tsoi, L. C., Kidder, A., Xing, X., White, B. E. P., Shao, S., Plazyo, O., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci159393 · Cited by 25
“HPV infections classically involve the mid to upper layers of the epider-mis (27), where HPV genome amplification occurs (28).”
BackgroundQin, W., Wang, S., Min, Y., Liu, X., Fang, J., Lang, J., & Chen, M. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03599-1 · Cited by 29
Waldstrøm, M., & Ørnskov, D. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0411-oar · Cited by 23
“It is widely accepted that for HPV to cause cervical cancer, persistent infection and a cellular environment that allows high expression of the viral oncogenes E6 and E7 are necessary.(7) The E6 and E7 oncogenes are necessary for viral replication.”
BackgroundZhou, Y., Zhang, Q., Gao, G., Zhang, X., Liu, Y., Yuan, S., Wang, X., & Chen, J. J. (2016) · Journal of Virology · doi:10.1128/jvi.00513-16 · Cited by 23
Okonogi, N., Kobayashi, D., Suga, T., Imai, T., Wakatsuki, M., Ohno, T., Kato, S., Nakano, T., & Kamada, T. (2017) · Oncology Letters · doi:10.3892/ol.2017.7327 · Cited by 23
“Two HPV species, α -7 (HPV 18, 39, 45, 59, and 68) and α -9 (HPV 16, 31, 33, 35, 52, and 58), account for >80% of all CCs (19).”
Current strategies against persistent human papillomavirus infection (Review)
Liu, Y., Li, H., Pi, R., Yang, Y., Zhao, X., & Qi, X. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4847 · Cited by 23
“Thus, coordination of E6 and E7 drives cells to re-enter the cell cycle (35).”
BackgroundNicol, C., Bunka, D. H. J., Blair, G. E., & Stonehouse, N. J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.044 · Cited by 23
Bhattacharjee, B., Mondal, N. R., Roy, S. S., & Sengupta, S. (2008) · Virology · doi:10.1016/j.virol.2008.04.007 · Cited by 25
“The sequence analysis of the E1 ORF was not incorporated in this study, because it is the most highly conserved of all ORFs among the various HPV types (Doorbar, 2006).”
BackgroundHigh-risk HPV16E6 stimulates hADA3 degradation by enhancing its SUMOylation
Chand, V., John, R., Jaiswal, N., Johar, S. S., & Nag, A. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu104 · Cited by 18
Choi, Y. J., Lee, A., Kim, T. J., Jin, H.-T., Seo, Y.-B., Park, J. S., & Lee, S. J. (2018) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2018.29.e38 · Cited by 22
“The production of HPV L1 protein is halted after the integration of HPV into the host's genome, owing to the loss of HPV L1 gene in the infected cell [24].”
BackgroundHPV-associated cancers: insights into the mechanistic scenario and latest updates
Mukherjee, A. G., Wanjari, U. R., Gopalakrishnan, A. V., Jayaraj, R., Katturajan, R., Kannampuzha, S., Murali, R., Namachivayam, A., Prince, S. E., Vellingiri, B., et al. (2023) · Medical Oncology · doi:10.1007/s12032-023-02085-8 · Cited by 23
Genetic variants in interleukin-18 gene and risk for cervical squamous cell carcinoma
Yang, Y., Chang, T., Chen, T.-C., Chang, S.-C., Lin, W., & Lee, Y. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.04.001 · Cited by 23
Rebolj, M., Preisler, S., Ejegod, D. M., Bonde, J. H., Rygaard, C., & Lynge, E. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.04.002 · Cited by 22
Singh, A. K., & Misra, K. (2013) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-013-0159-8 · Cited by 22
Lucs, A. V., Saltman, B. E., Chung, C. H., Steinberg, B. M., & Schwartz, D. L. (2012) · Head & Neck · doi:10.1002/hed.21975 · Cited by 24
“Human papillomavirus (HPV) is a DNA virus that infects skin and mucosal epithelium.(19,20) It causes both benign and malignant tumors but can also exist in latent form, with no evidence of pathology.”
BackgroundHuman papillomavirus in ameloblastoma
Correnti, M., Rossi, M., Ãvila, M., Marianella Perrone, C., & Rivera, H. (2010) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2010.04.030 · Cited by 22
Fan, X., Yu, K., Wu, J., Shao, J., Zhu, L., & Zhang, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2940-7 · Cited by 22
“The correlation between HPV and cervical intraepithelial neoplasia (CIN), an invasive SQC, is well known all over the world [17, 18].”
BackgroundIGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (Review)
Durzyńska, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3505 · Cited by 22
“represents an abortive infection in which viral gene expression becomes deregulated, and the normal life cycle of the virus cannot be completed (41).”
BackgroundRen, C., Zhu, Y., Yang, L., Zhang, X., Liu, L., & Ren, C. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4588-1 · Cited by 22
Khadela, A. D., Shah, Y. B., Mistry, P. S., Bodiwala, K. B., & Avinash, C. B. (2023) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221150559 · Cited by 22
Dutta, S., Chakraborty, C., Dutta, A. K., Mandal, R., Roychoudhury, S., Basu, P. S., & Panda, C. K. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202611 · Cited by 21
Wang, H.-Y., Lee, D., Park, S., Kim, G., Kim, S., Han, L., Yubo, R., Li, Y., Park, K. H., & Lee, H. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.17.7633 · Cited by 23
Wei, Y., Sun, J., & Li, X. (2016) · Biotechnology Letters · doi:10.1007/s10529-016-2251-8 · Cited by 21
“It is a tumor suppressor protein that is dysfunctional in several major cancers, including osteosarcoma (Deshpande and Hinds 2006), cervical carcinoma (Doorbar 2006), liver cancer (Munakata et al. 2007) and gastric cancer (Cito et al. 2010).”
BackgroundRetractedHuman papillomavirus and oropharyngeal cancer
Villa, A., & Hanna, G. J. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.06.005 · Cited by 21
Metadata
- Authors
- Doorbar, J.
- Affiliations
- National Institute for Medical Research (GB)
- Corresponding author
- Doorbar, John
- ORCID
- Doorbar, John
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2006-04-11
- Volume
- 110
- Issue
- 5
- Pages
- 525-541
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2052489835
- Cited by
- 1,072
- References
- 179
- Citations by year
- 2026: 30 · 2025: 35 · 2024: 34 · 2023: 41 · 2022: 51 · 2021: 43 · 2020: 52 · 2019: 45 · 2018: 60 · 2017: 55 · 2016: 58 · 2015: 64 · 2014: 73 · 2013: 98 · 2012: 83
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human papillomavirus, cervical cancer, HPV16, high-risk HPV, viral gene expression, cervical neoplasia, cervical transformation zone, E6 oncoprotein, E7 oncoprotein, retinoblastoma protein, p53 degradation, PDZ domain proteins, abortive infection, viral latency, immune clearance
- MeSH terms
- Uterine Cervical Neoplasms, Female, Humans, Precancerous Conditions, Virus Latency, Disease Progression, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.